1;Contents;6 2;List of Participants;11 3;Johann Lukas Schoenlein Prize 2006;33 4;I. Epidemiology;35 4.1;HIV Infection and Causes of Death in Patients with Hemophilia in Germany ( Year 2005/ 2006 Survey);36 4.2;Hemophilia Registry of the Medical Committee of the Swiss Hemophilia Association - Update and Annual Survey 2006;48 5;II. Treatment of Inhibitors in Hemophiliacs;53 5.1;Detection of Factor VIII- Specific Memory B Cells in Patients with Hemophilia A and Factor VIII Inhibitors;54 5.2;Novel Strategies for FVIII: Half- life Prolongation;66 6;III. Hemophilic Arthropathy and Synovitis;67 6.1;Predictive Parameters of Fitness in Hemophiliac Children;68 6.2;Hemophilia and Exercise Project ( HEP) Conception and Contents of a "Programmed Sports Therapy" for Hemophilic Patients;72 6.3;Results of German Hemophiliacs Self-Assessment of Health and Social Status: With Emphasis on Orthopedic Function;87 7;IV. Relevant Hemophilia Treatment 2006;91 7.1;Developing a German Hemophilia Register;92 8;V. Pediatric Hemostasiology;93 8.1;Thrombin Generation in Children with Hemophilia and VWD - Comparing a Fluorimetric Method and ROTEM;94 8.2;Thrombin Generation in Severely Obese Children;98 8.3;Protein C Promoter Genotypes Associate with Susceptibility, Development of Sepsis, and Lower Blood Pressure in Young Children with Systemic Meningococcemia;104 8.4;Life of Teenage Hemophiliacs;111 9;VI. Free Lectures;115 9.1;Monocytes Enhance rVIIa Induced Thrombin Generation in Absence of Platelets and Microparticles;116 9.2;Mutation Detection Rate in Female Patients with Reduced Factor VIII Activity and Negative Family History for Hemophilia A;127 9.3;Investigation of Underlying Reasons of Factor VIII Deficiency in Hemophilia A Patients with Undetectable Mutations in the F8 Gene;130 9.4;Monitoring of Antiplatelet Therapy Using Whole Blood Aggregometry: Experiences and Approaches to Dose Adaptation;135 10;VII. Poster VIIa: Hemophilia;137 10.1;No Complications in Switching from Recombinate to Advate - a Prospective Surveillance in 22 Children;138 10.2;Epidemiology and Treatment of Hemophilia A, B and von Willebrand Disease of Type 3 in the Eastern Part of German;141 10.3;Database Management System for a Hemophilia Comprehensive Care Center;144 10.4;Hepatocellular Carcinoma in Patients with Hemophilia and Chronic Hepatitis C Infection;146 10.5;Elucidation of Gross Genomic Rearrangements Involving Large Deletions in the Clotting Factor VIII Gene;149 10.6;The Centro American Hemophilia Registry, of the CARS Hemophilia Group - Update September 2006;157 10.7;Two Examples of the Influence of Psychological Stress on the von Willebrand Factor Activity;161 10.8;Efficacy of Chronic Hepatitis C Treatment in Hemophilic Patients During the Last 10 Years: a Single Center Experience;164 10.9;Dynamic of Thrombin Generation in Patients with Severe Hemophilia A;168 10.10;Hemophilia and Exercise Project ( HEP): Effects of a Two- Year Sports Therapy on Physical Activity Behavior and Bleeding Frequency by Persons with Hemophilia;171 10.11;Hemophilia Summer Camp in Germany, 1996- 2005;172 10.12;Impact of Hemophilia on the Psychological Health of Hemophilia Patients in Romania;173 10.13;Starter- Kit for Patients Suffering from Hemophilia - A Project Initiated by the German Hemophilia Assistant Committee;179 10.14;Documentation in Hemophilia Treatment;182 10.15;Short-time Prophylaxis with FEIBA in Three Patients with Hemophilia A and High Titer Inhibitors;184 11;VIIb. Casuistics;187 11.1;Successful Treatment of a Patient with High Titer Acquired Factor VIII Inhibitor ( 114 BU) with Rituximab;188 11.2;Preoperative Arterial Embolization of a Hemophilic Pseudo Tumor before Osteosynthesis in a Patient with Hemophilia A and Pathological Femoral Fracture;191 11.3;Successful Liver Transplantation in Two Patients with Severe Hemophilia A;195 11.4;Out from the Cold: Severe Erythema and Clumped Red Cells;198 11.5;Acquired Glanzmann Thrombasthenia in a Patient with Myelodysplastic Syndrome